AbbVie, Inc. ABBV
NYSE · United States · Health Technology
$261.59-1.70 (-0.65%)
Market closed· · USD · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
Market closed· · USD · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
| Quarter | Report date | Actual EPS | Estimated EPS | EPS surprise | Actual revenue | Revenue surprise | Price reaction |
|---|---|---|---|---|---|---|---|
| Q2 2026 | 2026-07-31 | 3.65 | 3.61 | +1.2% | $16.99B | +1.1% | -4.8%$257.41→$245.10 |
| Q1 2026 | 2026-04-29 | 2.65 | 2.67 | -0.7% | — | — | +6.9%$197.69→$211.32 |
| Q4 2025 | 2026-02-04 | 2.71 | 2.65 | +2.3% | — | — | -2.9%$225.66→$219.02 |
| Q3 2025 | 2025-10-31 | 1.86 | 1.78 | +4.5% | — | — | -7.1%$228.20→$211.96 |
| Q2 2025 | 2025-07-31 | 2.97 | 2.91 | +2.1% | — | — | — |
| Q1 2025 | 2025-04-25 | 2.46 | 2.40 | +2.5% | — | — | — |
| Q4 2024 | 2025-01-31 | 2.16 | 2.12 | +1.9% | — | — | — |
| Q3 2024 | 2024-10-30 | 3.00 | 2.92 | +2.7% | — | — | — |
The price reaction is the change from the last close before the announcement date to the first close after it - the report may land before the open, during the session or after the close, so this window covers all three. Not investment advice.